Department of Radiation Oncology and Medical Physics, Tata Memorial Hospital, Parel, Mumbai, India.
Int J Gynecol Cancer. 2012 Oct;22(8):1427-34. doi: 10.1097/IGC.0b013e3182664b46.
To compare volumes and dose volume histogram (DVH) parameters for bone marrow contours using 2 methods on computed tomography (CT) and correlation with grade 2 or higher hematological toxicity (HT) in patients with cervical cancer treated with non-bone marrow-sparing intensity-modulated radiotherapy (IMRT) with concurrent cisplatin.
The planning CT scans of 47 patients prospectively enrolled and treated with IMRT arm of a phase 2 trial (NCT00193804) contoured for pelvic bone marrow in 2 sets; whole bone (WB), and freehand (FH) inner cavity of bone. Various subvolumes were made in each set--sacrum, ilium, ischium, lower pelvis, lumbosacral spine, sacrum, and whole pelvis--and compared for volume and DVH parameters (V(10), V(20), V(30), and V(40)) using paired t test. The hematological parameters during RT compiled from electronic database analyzed for higher than grade 2 (Radiation Therapy Oncology Group) HT and correlated with DVH parameters using log regression analysis (P < 0.05 significant).
The FH subvolumes were 25% to 30% of WB. The mean DVH parameters V(10), V(20), V(30), and V(40) for whole-pelvis FH and WB were 86.5%, 77.5%, 62.5%, and 40.5%; and 88%, 79.6%, 62.9%, and 40%, respectively. There was significant difference between the DVH parameters of 2 sets (P < 0.05) for all subvolumes except ischium V(20), sacrum V(10), and lumbosacral spine V(10). The leukopenia, neutropenia, anemia, and thrombocytopenia higher than grade 2 was seen in 53%, 29.8%, 65.9%, and 10.6%, respectively. The mean V(10) for whole pelvis was less than 90% for both sets. On both univariate and multivariate analyses, only FH whole pelvis V(40) more than or equal to 40% correlated with higher than grade 2 leukopenia (Mann-Whitney U test, P = 0.026) and neutropenia (P = 0.05) with odds ratio, 4 (95% confidence interval, 1.166-13.728; P = 0.028).
The FH bone marrow cavity volume is a better surrogate of active bone marrow on CT images and correlated with higher than grade 2 HT (V(40) >40%). Further prospective studies validating significance of high-dose effects and identifying correlation of bioimaging with CT contouring are warranted.
比较两种方法在宫颈癌患者非骨髓保护调强放疗(IMRT)同期顺铂治疗中 CT 上勾画骨髓的体积和剂量体积直方图(DVH)参数,并与 2 级或以上血液学毒性(HT)相关。
前瞻性纳入并接受 2 期试验(NCT00193804)IMRT 臂治疗的 47 例患者的计划 CT 扫描,在 2 组中进行骨盆骨髓勾画:全骨(WB)和徒手(FH)骨内腔。在每组中制作各种子体积 - 骶骨、髂骨、坐骨、下骨盆、腰骶脊柱、骶骨和整个骨盆 - 并使用配对 t 检验比较体积和 DVH 参数(V(10)、V(20)、V(30)和 V(40))。从电子数据库中编译 RT 期间的血液学参数,分析 2 级以上(放射治疗肿瘤学组)HT,并使用对数回归分析与 DVH 参数相关(P <0.05 有意义)。
FH 子体积占 WB 的 25%至 30%。整个骨盆 FH 和 WB 的平均 DVH 参数 V(10)、V(20)、V(30)和 V(40)分别为 86.5%、77.5%、62.5%和 40.5%;和 88%、79.6%、62.9%和 40%,分别。除坐骨 V(20)、骶骨 V(10)和腰骶脊柱 V(10)外,2 组的 DVH 参数之间存在显著差异(P <0.05)。白细胞减少症、中性粒细胞减少症、贫血和血小板减少症分别为 53%、29.8%、65.9%和 10.6%。2 组的全骨盆平均 V(10)均小于 90%。在单变量和多变量分析中,只有 FH 全骨盆 V(40)大于或等于 40%与 2 级以上白细胞减少症(Mann-Whitney U 检验,P = 0.026)和中性粒细胞减少症(P = 0.05)相关,优势比为 4(95%置信区间,1.166-13.728;P = 0.028)。
FH 骨髓腔体积是 CT 图像上活性骨髓的更好替代物,与 2 级以上 HT(V(40)>40%)相关。需要进一步的前瞻性研究来验证高剂量效应的意义,并确定生物影像学与 CT 勾画的相关性。